Literature DB >> 16954275

Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.

Thomas E Dobbs1, Mukesh Patel, Ken B Waites, Stephen A Moser, Alan M Stamm, Craig J Hoesley.   

Abstract

In May 2004 our institution encountered its first clinical isolate of linezolid-resistant, vancomycin-resistant Enterococcus faecium (LRVRE). Between October 2004 and July 2005, 40 patients from whom LRVRE organisms were recovered in clinical specimens were characterized. Epidemiologic investigation and pulsed-field gel electrophoresis patterns indicated a clonal outbreak related to nosocomial spread.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16954275      PMCID： PMC1594671          DOI： 10.1128/JCM.00850-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.

Authors:  Inmaculada A Herrero; Nicolas C Issa; Robin Patel
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

2.  Emergence of linezolid-resistant Enterococcus faecium during treatment of enterococcal infections.

Authors:  M Bassetti; P A Farrel; D A Callan; J E Topal; L M Dembry
Journal:  Int J Antimicrob Agents       Date:  2003-06       Impact factor: 5.283

3.  Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.

Authors:  S H Marshall; C J Donskey; R Hutton-Thomas; R A Salata; L B Rice
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

4.  Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment.

Authors:  M G Bonora; M Ligozzi; A Luzzani; M Solbiati; E Stepan; R Fontana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

5.  In vitro activity of linezolid against key gram-positive organisms isolated in the united states: results of the LEADER 2004 surveillance program.

Authors:  Deborah C Draghi; Daniel J Sheehan; Patricia Hogan; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

6.  Linezolid-resistant enterococci: report of the first isolates in the United Kingdom.

Authors:  Cressida Auckland; Louise Teare; Fiona Cooke; Mary E Kaufmann; Marina Warner; Graeme Jones; Kathy Bamford; Helen Ayles; Alan P Johnson
Journal:  J Antimicrob Chemother       Date:  2002-11       Impact factor: 5.790

7.  Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.

Authors:  A P Johnson; L Tysall; M V Stockdale; N Woodford; M E Kaufmann; M Warner; D M Livermore; F Asboth; F J Allerberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-09-13       Impact factor: 3.267

Review 8.  Vancomycin-resistant enterococci: 15 years and counting.

Authors:  L S Chavers; S A Moser; W H Benjamin; S E Banks; J R Steinhauer; A M Smith; C N Johnson; E Funkhouser; L P Chavers; A M Stamm; K B Waites
Journal:  J Hosp Infect       Date:  2003-03       Impact factor: 3.926

Review 9.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

10.  Optimization of computer software settings improves accuracy of pulsed-field gel electrophoresis macrorestriction fragment pattern analysis.

Authors:  William M Duck; Christine D Steward; Shailen N Banerjee; John E McGowan; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948
View more
  16 in total

1.  In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.

Authors:  Laura Lawrence; Paul Danese; Joe DeVito; Francois Franceschi; Joyce Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

2.  Outcomes of invasive infection due to vancomycin-resistant Enterococcus faecium during a recent outbreak.

Authors:  C Theilacker; D Jonas; J Huebner; H Bertz; W V Kern
Journal:  Infection       Date:  2009-12       Impact factor: 3.553

3.  Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates.

Authors:  E-M Klupp; A Both; C Belmar Campos; H Büttner; C König; M Christopeit; M Christner; M Aepfelbacher; H Rohde
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-15       Impact factor: 3.267

4.  R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.

Authors:  Eugene Skripkin; Timothy S McConnell; Joseph DeVito; Laura Lawrence; Joseph A Ippolito; Erin M Duffy; Joyce Sutcliffe; François Franceschi
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

5.  Response to emerging infection leading to outbreak of linezolid-resistant enterococci.

Authors:  Marion A Kainer; Rose A Devasia; Timothy F Jones; Bryan P Simmons; Kelley Melton; Susan Chow; Joyce Broyles; Kelly L Moore; Allen S Craig; William Schaffner
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

6.  Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistant Enterococcus faecium.

Authors:  B Schulte; A Heininger; I B Autenrieth; C Wolz
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

7.  Clinical results of linezolid in arthroplasty and trauma MRSA related infections.

Authors:  James Joel; Simon Matthew Graham; Adam Peckham-Cooper; Nectarios Korres; Helen Tsouchnica; Eleftherios Tsiridis
Journal:  World J Orthop       Date:  2014-04-18

8.  Linezolid- and Vancomycin-resistant Enterococcus faecium in Solid Organ Transplant Recipients: Infection Control and Antimicrobial Stewardship Using Whole Genome Sequencing.

Authors:  Lilian Abbo; Bhavarth S Shukla; Amber Giles; Laura Aragon; Adriana Jimenez; Jose F Camargo; Jacques Simkins; Kathleen Sposato; Truc T Tran; Lorena Diaz; Jinnethe Reyes; Rafael Rios; Lina P Carvajal; Javier Cardozo; Maribel Ruiz; Gemma Rosello; Armando Perez Cardona; Octavio Martinez; Giselle Guerra; Thiago Beduschi; Rodrigo Vianna; Cesar A Arias
Journal:  Clin Infect Dis       Date:  2019-07-02       Impact factor: 9.079

9.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

10.  Maternal transmission of mutans Streptococci in severe-early childhood caries.

Authors:  Stephen C Mitchell; John D Ruby; Stephen Moser; Stephanie Momeni; Anita Smith; Robert Osgood; Mark Litaker; Noel Childers
Journal:  Pediatr Dent       Date:  2009 May-Jun       Impact factor: 1.874
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.